Kawasaki Disease (Mucocutaneous Lymph Node Syndrome) Medications
Definition of Kawasaki Disease: A non-specific disease, with no apparent infectious agent, that affects the mucus membranes, lymph nodes, lining of the blood vessels, and the heart.
Drugs (by generic name) associated with Kawasaki Disease
The following drugs and medications are in some way related to, or used in the treatment of Kawasaki Disease. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
| Drug Name |
Reviews | Ratings |
||
|---|---|---|---|---|
| aspirin systemic (Pro, More...) class: platelet aggregation inhibitors, salicylates | 0 review(s) | Rate It! | 5.5 | |
| infliximab systemic (Pro, More...) class: antirheumatics, TNF alfa inhibitors | 0 review(s) | Not rated Be the first |
||
| immune globulin intravenous systemic (Pro, More...) class: immune globulins | 0 review(s) | Not rated Be the first |
||
| aluminum hydroxide/aspirin/calcium carbonate/magnesium hydroxide systemic (More...) class: salicylates | 0 review(s) | Not rated Be the first |
||
